MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2022-23)
- Udyam number
- UDYAM-TS-02-0006134
Sakksa Pharma Private Limited
Sakksa Pharma Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹15,400
Latest filing
Net loss · FY 2025
₹1,288
Net margin -8.4%
EBITDA · FY 2025
-₹1,721
EBITDA margin -11.2%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered
About Sakksa Pharma Private Limited
Data last updated:
Sakksa Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 12 December 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24304TG2019PTC137524. Its GSTIN is 36ABDCS0587P1ZP (Telangana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Sureshbabu Makam and Javvaji Anil Kumar Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No.576 Flat No.302 Ananda Nilayam Near Bsnl Exchange Mig2 Kphb Colony, Hyderabad, Telangana, India – 500085.
As per the financials filed for FY 2025, the company reported a revenue of ₹15,400. For the same year it recorded a net loss of ₹1,288 (net margin -8.4%) and EBITDA of -₹1,721 (EBITDA margin -11.2%).
Sakksa Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0006134).
Company details
CIN U24304TG2019PTC137524
Registration Number 137524
Incorporation Date 12 December 2019
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-TS-02-0006134
Key People
Sureshbabu Makam Director Javvaji Devi Aruna Additional Director Javvaji Anil Kumar Gupta Director Recognitions & Rankings of Sakksa Pharma
Contact details
Sakksa Pharma Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No.576 Flat No.302 Ananda Nilayam Near Bsnl Exchange Mig2 Kphb Colony, Hyderabad, Telangana, India – 500085
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Sakksa Pharma Private Limited, buy the company report.
Comprehensive company report
Sakksa Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Sakksa Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Sakksa Pharma Private Limited, buy the company report.
Financials of Sakksa Pharma Private Limited
FY 2025 filings availableSakksa Pharma Private Limited reported revenue of ₹15,400 for FY 2025.
Revenue · FY 2025
₹15,400
Net loss · FY 2025
₹1,288 margin -8.4%
EBITDA · FY 2025
-₹1,721 margin -11.2%
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1,721 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1,288 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -11.2% | ||||
| Net Profit Margin | -8.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sakksa Pharma Private Limited, buy the company report.
Board of directors of Sakksa Pharma Private Limited
Sakksa Pharma has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sureshbabu Makam Also directs: MMC Pharmaceuticals Limited, Surax Research Labs Private Limited, Roorkee Research & Analytical Labs Private Limited and 1 more | Director | 12 Dec 2019 | 6 Years 10 Months | Current |
| Javvaji Devi Aruna Also directs: Scoat Pharma Private Limited | Additional Director | 09 Jan 2021 | 5 Years 9 Months | Current |
| Javvaji Anil Kumar Gupta Also directs: Boffin Pharmamed Solutions LLP, Scoat Pharma Private Limited | Director | 12 Dec 2019 | 6 Years 10 Months | Current |
Auditor
Sakksa Pharma Private Limited is audited by KRISHNA RAO & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KRISHNA RAO & ASSOCIATES | FY 2022 | 011298S |
Shareholding
The shareholding of Sakksa Pharma Private Limited is on record for 3 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Sakksa Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Sakksa Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sakksa Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sakksa Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36ABDCS0587P1ZP | Telangana | Active | 20 Mar 2021 |
To see the full GST registrations and return filing status of Sakksa Pharma Private Limited, buy the company report.
Recent activity
Sakksa Pharma Private Limited has 4 board changes on record since 2019: 3 appointments and 1 cessation. The latest: Anjali Patidar ceased to be Additional Director on 01 Mar 2023.
AGM
Sakksa Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Sakksa Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Ceased
Anjali Patidar ceased to be Additional Director.
Appointed
Javvaji Devi Aruna was appointed as Additional Director.
Appointed
Javvaji Anil Kumar Gupta was appointed as Director.
Appointed
Sureshbabu Makam was appointed as Director.
Incorporation
12 Dec 2019
Sakksa Pharma Private Limited was registered on 12 Dec 2019 with Roc Hyderabad & aged 6 years 10 months as per MCA records.
Frequently asked questions
Sakksa Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 12 December 2019 (7+ years old) and is registered under CIN U24304TG2019PTC137524.
Sakksa Pharma has 3 current directors:
- Sureshbabu Makam - Director
- Javvaji Devi Aruna - Additional Director
- Javvaji Anil Kumar Gupta - Director
The latest financial statements of Sakksa Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Sakksa Pharma is 36ABDCS0587P1ZP, registered in Telangana.
The CIN (Corporate Identification Number) of Sakksa Pharma is U24304TG2019PTC137524. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sakksa Pharma was incorporated on 12 December 2019, making it 7+ years old. It is registered with the Registrar of Companies, Hyderabad.
Anjali Patidar ceased to be Additional Director on 01 Mar 2023. Javvaji Devi Aruna was appointed as Additional Director on 09 Jan 2021. Javvaji Anil Kumar Gupta was appointed as Director on 12 Dec 2019. Sakksa Pharma has 4 board changes on record in total.
Yes, Sakksa Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-02-0006134).
The registered office of Sakksa Pharma is at Plot No.576 Flat No.302 Ananda Nilayam Near Bsnl Exchange Mig2 Kphb Colony, Hyderabad, Telangana, India – 500085.
Sakksa Pharma operates in the pharma industry, in the drug formulation and development segment.